U.S. Banks Stock News

Event Trigger: Operational Pressures Behind Steven Madden’s Valuation Steven Madden (SHOO) is in focus after concerns around weaker annual revenue growth, softer free cash flow margin, and diminishing returns on capital highlighted ongoing operational pressures, despite the brand’s ongoing appeal to younger shoppers. See our latest analysis for Steven Madden. At a share price of US$39.19, Steven Madden has seen some pressure recently, with a 30-day share price return of a 14.06% decline...

Noble (NE) is back in focus after mixed fourth quarter 2025 results, softer 2026 revenue guidance of US$2.8b to US$3.0b, and a US$0.50 quarterly dividend, even as analysts have turned more optimistic. See our latest analysis for Noble. That backdrop helps explain why Noble’s recent earnings miss and softer 2026 revenue guidance have not stopped the share price from climbing. A 30 day share price return of 40.17% and a 1 year total shareholder return of 69.57% suggest momentum has been...

If you are trying to figure out whether Crescent Energy at around US$10.23 is a bargain or a value trap, you are in the right place. The stock is up 22.1% over the last 30 days and 20.2% year to date, even though the 1 year return sits at a 27.6% decline and the 7 day move is a modest 0.7% decline. Recent news coverage has focused on Crescent Energy's position in the US energy sector and how its share price has been reacting to changes in investor sentiment toward oil and gas producers...

Cabot (CBT) shares are under the microscope after the company reported first quarter results, showing sales of US$849 million and net income of US$73 million, both lower than in the same period a year earlier. See our latest analysis for Cabot. Despite the softer quarterly numbers, Cabot's 30 day share price return of 7.43% and 90 day share price return of 27.49% suggest momentum has been building, even though the 1 year total shareholder return of an 11.71% decline shows a weaker longer term...

Daktronics (DAKT) has drawn fresh attention after recent share price moves, with the stock up 5.2% over the past day, 6.0% over the past week and 26.7% over the past month. See our latest analysis for Daktronics. The latest 1 month share price return of 26.7% sits within a broader upswing, with the 90 day share price return at 51.9% and the 1 year total shareholder return at 71.1%. This indicates that momentum has been building rather than fading over time. If Daktronics’ move has you...

In its fourth-quarter 2025 investor letter, Praetorian Capital highlighted The St. Joe Company’s roughly 167,000 acres of Florida Panhandle land and argued the business could grow revenue and earnings rapidly while trading at what it views as an appealing Adjusted Funds from Operations multiple. This commentary effectively frames St. Joe as a land-rich owner where investors may be paying for cash flow while receiving significant asset value at little apparent cost. We’ll now examine how...

If you are wondering whether Agilysys at around US$81.50 is priced for opportunity or already reflecting much of its prospects, this article is for you. The stock has seen sharp recent moves, with a 5.3% decline over the last 7 days, a 28.4% decline over the last 30 days and a 29.4% decline year to date, while the 5 year return sits at 35.9%. These swings have come as investors react to ongoing developments in the broader software sector and shifting sentiment toward growth oriented names,...

Vertex Pharmaceuticals reported full-year 2025 results showing revenue of US$12.00 billion, up from US$11.02 billion a year earlier, with net income of US$3.95 billion replacing a net loss and earnings per share turning positive on both a basic and diluted basis. Alongside this earnings shift, Vertex issued 2026 guidance that points to an increasing contribution from non-cystic fibrosis products such as CASGEVY and JOURNAVX, supported by a new trispecific T‑cell engager collaboration with...

Multiple securities fraud class action lawsuits have been filed against Oracle (NYSE:ORCL) over its disclosures on AI infrastructure spending and revenue potential. Claims focus on allegedly misleading statements about costs, data center timelines, and reliance on large capital raises tied to AI related cloud contracts. The cases center on whether investors were given a full picture of financial and operational risks linked to Oracle's AI infrastructure build out. Oracle sits at the...

Recently, analysts highlighted Sanmina as a top pick for growth investors, assigning it a #1 Zacks Rank and an A VGM Score, supported by upward earnings estimate revisions. This recognition emphasizes how analyst expectations around Sanmina's earnings strength and quality metrics are becoming central to the company’s investment case. Next, we'll examine how this upgraded analyst sentiment, especially the strong Growth Style Score, interacts with Sanmina's existing investment narrative. This...

Earlier in February 2026, Willis Towers Watson released a next-generation upgrade of its RiskAgility FM U.S. Library models, fully embedding VM-22 reserving requirements for non-variable annuities and offering insurers an integrated, production-ready platform for statutory valuation. This enhancement reinforces WTW’s role in complex actuarial and risk software at a time when insurers face heavier regulatory and modeling demands across annuity and pension risk transfer portfolios. We’ll now...

Hayward Holdings: Recent Returns and Business Snapshot Hayward Holdings (HAYW) has drawn attention after a mix of short term share moves, including a small gain over the past week and a modest decline over the past month, alongside stronger performance over the past three months. For context, the company reports annual revenue of US$1.10b and net income of US$137.9m, supported by positive annual growth in both metrics. This provides investors with a concrete baseline for assessing the pool...

Rebranding highlights resilience and improving profitability Recent commentary on Baldwin Insurance Group (BWIN) focuses on its rebranding from BRP Group in May 2024 and the continued strength in organic revenue growth, margin expansion, and earnings per share performance. See our latest analysis for Baldwin Insurance Group. Despite the rebrand and solid operating metrics, Baldwin Insurance Group’s recent trading tells a different story, with a 30 day share price return of 38.06% decline and...

Harel Insurance Investments & Financial Services Ltd. recently increased its holdings in ICL Group to 56,619,519 shares, making the company a larger component of its investment portfolio and signaling renewed institutional interest in the specialty minerals and chemicals producer. This move highlights how a large domestic financial institution is leaning into ICL’s role in mineral-based products and crop nutrition at a time when sector expectations and operational challenges remain in...

XPO (XPO) stock is back in focus after a downgrade to Neutral, sector wide AI worries, freight regulation headlines, and renewed attention on the company’s recent earnings and share repurchase activity. See our latest analysis for XPO. Despite the recent downgrade and sector worries, XPO’s share price has climbed strongly, with a 30 day share price return of 29.87% and a 90 day share price return of 51.62%, while the 3 year total shareholder return is very large at about 4x. This mix of short...

Recently, several brokerages reaffirmed bullish views on On Holding AG, while the company appointed Frank Sluis as its new Chief Financial Officer effective May 1, 2026, separating the previously combined CEO/CFO role. This combination of strong analyst conviction and a leadership refresh in the finance function has reinforced investor confidence in On’s long-term growth ambitions within global sportswear. We’ll now examine how the appointment of an experienced CFO and renewed analyst...

BWX Technologies (BWXT) has put its digital agenda in the spotlight by opening a new Digital Center in Melbourne, Florida, and appointing Kurt Bender as senior vice president and chief digital officer. See our latest analysis for BWX Technologies. BWX Technologies’ recent digital push comes as the share price sits at $200.40, with a 90 day share price return of 13.92% and a very large 5 year total shareholder return of 269.04%. This suggests momentum has been building over time, despite a...

Recent performance puts Himax Technologies (HIMX) back on investors’ radar Himax Technologies (HIMX) has seen mixed share performance recently, with a 10.1% decline over the past month but a 7.2% gain over the past 3 months. This has prompted closer attention from investors. See our latest analysis for Himax Technologies. At a share price of US$7.72, Himax’s recent 1-month share price return of a 10.1% decline and 7.2% gain over 3 months suggest momentum has cooled in the short term...

Earlier this month, Trane Technologies announced that its Board approved a 12% increase in the quarterly dividend to US$1.05 per ordinary share (US$4.20 annualized), payable on March 31, 2026 to shareholders of record on March 6, 2026. In addition, the company is scheduled to present at the Barclays 43rd Annual Industrial Select Conference in Miami Beach on February 17, 2026, giving management a platform to explain how the higher dividend fits into its broader capital allocation and growth...

Citigroup’s fresh Buy initiation on Adecoagro (NYSE:AGRO) on February 16, 2026, paired with its Zacks Rank #1 (Strong Buy) value rating, is putting this agricultural producer squarely on many investors’ watchlists. See our latest analysis for Adecoagro. At a share price of $8.65, Adecoagro has had a mixed run. Its 30-day share price return is 5.75% and its 90-day share price return is 10.19%, while its 1-year total shareholder return shows a decline of 7.93%. This contrasts with 3-year and...

What the latest earnings and guidance mean for Phibro Animal Health (PAHC) Phibro Animal Health (PAHC) has attracted fresh attention after releasing second quarter and six month results, updating its fiscal 2026 guidance, and affirming a quarterly dividend. For investors, the combination of reported sales, earnings, and forward guidance provides a clearer snapshot of how the business is currently performing and what management expects for the rest of the fiscal year. See our latest analysis...

Why Haemonetics Stock Is Drawing Investor Attention Haemonetics (HAE) has come onto investors' radar after a sharp share price pullback, with the stock showing negative returns over the past month and past 3 months despite positive annual revenue and net income growth. See our latest analysis for Haemonetics. The recent pullback fits into a weaker trend, with a 30 day share price return of about 20% and a 3 year total shareholder return of roughly a 29% decline, suggesting momentum has been...

In early February 2026, NOV Inc. reported fourth-quarter 2025 results showing quarterly revenue of US$2,277 million, a net loss of US$78 million, and US$70 million of goodwill and long-lived asset impairments, alongside guidance for a 1% to 3% year-over-year revenue decline in the first quarter of 2026. At the same time, management highlighted that tighter acquisition criteria, a completed buyback of 36,959,834 shares for US$544.64 million, and a focus on portfolio efficiency are intended to...

Wynn Resorts (WYNN) is back in focus after its latest quarterly update, where revenue was supported by Macau operations while profits declined as Las Vegas and Boston softened and earnings missed Wall Street expectations. See our latest analysis for Wynn Resorts. At a share price of $113.39, Wynn Resorts has had a mixed start to 2026. The stock saw a 1 day share price return of 5.14% after earnings volatility, but the year to date share price return shows a 7.49% decline. Meanwhile, the 1...